In 2023, the average length of stay for carcinoma in situ in UK hospitals stood at 2.0 days. The forecasted data from 2024 to 2028 shows a consistent decline in the average length of stay: remaining stable at 1.9 days for 2024 and 2025, gradually decreasing to 1.8 days in 2026, 1.7 days in 2027, and ultimately 1.6 days in 2028.
The year-on-year variation is anticipated at 0% for 2025, -5.3% for 2026 and 2027, and -5.9% for 2028. The compound annual growth rate (CAGR) over the five-year period is projected to reflect these consistent declines in length of stay.
Future trends to watch for include advancements in early detection and treatment technologies that could further reduce hospital stays. Enhancements in outpatient care and post-operative management could also drive the downward trend, potentially decreasing the average length of stay below forecasted figures.
